Key result
Routine angiographic follow-up after AMI PCI linked to ~232% higher MACE risk versus clinical follow-up.
Why the study?
Does routine angiographic follow-up compared to clinical follow-up improve 3-year clinical outcomes in AMI patients after PCI with DES?
Cohort (n=774)
No
Does routine angiographic follow-up compared to clinical follow-up improve 3-year clinical outcomes in AMI patients after PCI with DES?
Hazard Ratio: 3.32 (95% CI 1.92–5.73)
Absolute Event Rate: 22.5% vs 8%
p-value: p=<0.001
Routine angiographic follow-up after PCI for AMI increases the incidence of revascularization and MACE without improving hard outcomes like death or MI, suggesting clinical follow-up is sufficient for asymptomatic patients.
May support clinical over routine angiographic follow-up in asymptomatic post-PCI AMI patients; leaves open causality and need for RCTs.
PURPOSE: Differences in the utility of routine angiographic follow-up (RAF) and clinical follow-up (CF) after percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) are not well understood. The present study aimed to compare the 3-year clinical outcomes of RAF and CF in AMI patients who underwent PCI with drug-eluting stents (DES). MATERIALS AND METHODS: A total of 774 consecutive AMI patients who underwent PCI with DES were enrolled. RAF was performed at 6 to 9 months after index PCI (n=425). The remaining patients were medically managed and clinically followed (n=349); symptom-driven events were captured. To adjust for any potential confounders, a propensity score matched analysis was performed using a logistic regression model, and two propensity-matched groups (248 pairs, n=496, C-statistic=0.739) were generated. Cumulative clinical outcomes up to 3 years were compared between RAF and CF groups. RESULTS: During the 3-year follow-up period, the cumulative incidences of revascularization [target lesion revascularization: hazard ratio (HR), 2.40; 95% confidence interval (CI), 1.18-4.85; p=0.015, target vessel revascularization (TVR): HR, 3.33; 95% CI, 1.69-6.58; p=0.001, non-TVR: HR, 5.64; 95% CI, 1.90-16.6; p=0.002] and major adverse cardiac events (MACE; HR, 3.32; 95% CI, 1.92-5.73; p<0.001) were significantly higher in the RAF group than the CF group. However, the 3-year incidences of death and myocardial infarction were not different between the two groups. CONCLUSION: RAF following index PCI with DES in AMI patients was associated with increased incidences of revascularization and MACE. Therefore, CF seems warranted for asymptomatic patients after PCI for AMI.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2017) conducted a cohort in Acute myocardial infarction after percutaneous coronary intervention (n=774). Routine angiographic follow-up vs. Clinical follow-up was evaluated on Major adverse cardiac events (MACE) (HR 3.32, 95% CI 1.92-5.73, p=<0.001). Routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in acute myocardial infarction patients was associated with a significantly higher incidence of major adverse cardiac events (HR 3.32) compared to clinical follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: